Drug Research
Schrodinger Taps Google Clouds High-Performance Compute Solution to Bolster Its Drug Discovery Efforts
Schrödinger, Inc. announced it has entered into a three-year agreement with Google Cloud to substantially increase the speed and capacity of its physics-based computational platform for drug discovery. As part of the agreement, Schrödinger has selected Google Cloud as...
Drug Research
Merck working with EOS AMCM to produce next-generation 3D printed tablets
Merck, a leading science and technology company and AMCM, Starnberg, Germany, announced a cooperation agreement on the 3D printing of tablets. AMCM offers customized additive manufacturing solutions and is a sister company of 3D printing worldmarket leader EOS. The...
Press Releases
Cryoport and Inception Fertility Enter Into Agreement
Cryoport, Inc. , the world's leading temperature-controlled logistics company dedicated to the life sciences industry, announced a multi-year agreement with Inception Fertility, LLC , a Houston-based company which operates The Prelude Network, the largest and fastest growing network of...
Press Releases
Abpro Forms Strategic Partnership to Advance Two Bispecific Antibody Candidates in Asian Markets
Abpro, a biotechnology company dedicated to developing next-generation antibody therapeutics to improve the lives of patients with severe and life-threatening diseases, announced the formation of a strategic partnership to advance two bispecific antibodies in key Asian markets including Greater...
Press Releases
FDA approves GSKs Advil Dual Action with Acetaminophen for over-the-counter use in the United States
GlaxoSmithKline announced that the U.S. FDA has approved Advil Dual Action with Acetaminophen as an over-the-counter (OTC) product for pain relief. The exclusive formula is now the first FDA-approved OTC combination of ibuprofen and acetaminophen in the United States...
Drug Research
Catalent Announces Supplying Blueprint Medicines Precision Therapy AYVAKIT
Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, gene and cell therapies, and consumer health products, welcomes the announcement by Blueprint Medicines Corporation that the U.S. Food and Drug Administration (FDA)...
Clinical Trials
Rare Disease Patient Platform Raremark Partners With TriNetX
TriNetX, the global health research network that revolutionizes clinical research and enables discoveries through the generation of real-world evidence (RWE), announced that Raremark, a patient-data platform focused on rare disease, has partnered with the TriNetX network to bring more...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read